Show Summary Details
Page of

Introduction to economic evaluations in clinical trials 

Introduction to economic evaluations in clinical trials
Introduction to economic evaluations in clinical trials

Dr. Henry A. Glick

, Dr. Jalpa A. Doshi

, Dr. Seema S. Sonnad

, and Dr. Daniel Polsky

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 March 2021

It is becoming increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. Results of these analyses can aid in early adoption decisions for therapies, aid interested parties when making claims about a therapy’s cost-effectiveness, address requirements of regulatory bodies, and affect reimbursement decisions for medical therapies. This chapter sets the stage for our book, Economic Evaluation in Clinical Trials. It discusses the general issues related to use of data from clinical trials and then provides an outline of the issues that are discussed in the remainder of the book.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.